If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement
Cardiac surgeons say mitral regurgitation patients need to be better screened and counseled before getting a transcatheter repair
If MitraClip fails and a surgical repair is required, a late-breaking study presented at the 2021 AATS meeting showed 95 percent of patients will require a full surgical valve replacement.
May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting, and simultaneously published in the Journal of the American College of Cardiology (JACC), finds that patients suffering from severe mitral regurgitation should be carefully screened and counseled before undergoing transcatheter edge-to-edge mitral repair (TEER).[1] Data showed that up to 95 percent of patients who needed surgery after failed TEER could not have their valves repaired, and needed a full surgical mitral valve replacement to resolve the issue.
Majority of patients who needed surgery after failed TEER required mitral valve replacement
A new study, presented today at the AATS 101st Annual Meeting, and simultaneously published in the
Journal of the American College of Cardiology, finds that patients suffering from severe mitral regurgitation should be carefully screened and counselled before undergoing transcatheter edge-to-edge mitral repair (TEER).
Data showed that up to 95 percent of patients who needed surgery after failed TEER could not have their valves repaired, and needed mitral valve replacement to resolve the issue. The findings highlight the need to select patients carefully for TEER.
Related Stories
As a less invasive approach, TEER is an attractive alternative treatment to mitral valve surgery, particularly in older patients. However, TEER is not currently recommended for younger patients who benefit more from a surgical repair long-term. This caution is supported by this study of 463 patients which provide
E-Mail
Boston, MA (May 1, 2021) - A new study, presented today at the AATS 101st Annual Meeting, and simultaneously published in the
Journal of the American College of Cardiology, finds that patients suffering from severe mitral regurgitation should be carefully screened and counselled before undergoing transcatheter edge-to-edge mitral repair (TEER). Data showed that up to 95 percent of patients who needed surgery after failed TEER could not have their valves repaired, and needed mitral valve replacement to resolve the issue. The findings highlight the need to select patients carefully for TEER.
As a less invasive approach, TEER is an attractive alternative treatment to mitral valve surgery, particularly in older patients. However, TEER is not currently recommended for younger patients who benefit more from a surgical repair long-term. This caution is supported by this study of 463 patients which provides the first national data on surgical outcomes when TEER fails. The surgi
Heart in a Box Technology Expands Heart Transplant Window
Smidt Heart Institute uses Transmedics Organ Care System (OCS) to increase the geographic area of service to enable more organ transplants
The Transmedics Organ Care System (OCS) Heart, or “Heart in a Box,” enables transplant surgeons to travel to much farther destinations to procure transplant hearts by acting as a miniature intensive care unit that keeps the heart alive.
April 5, 2021 Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be spontaneous. At any given moment, they can get the call that a donor heart or lungs are available, requiring them to quickly board a private aircraft to procure the vital organs. But until recently, those flights were quick jaunts lasting no more than four hours the time a donor heart can survive on ice. Now that is all changing, thanks to a medical device called the Transmedics Organ Care System (OCS) Heart, or “Heart in a Box